1042 related articles for article (PubMed ID: 28054319)
1. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
Wang J; Ni J; Beretov J; Thompson J; Graham P; Li Y
Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
[TBL] [Abstract][Full Text] [Related]
5. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
Lee J; Kwon MH; Kim JA; Rhee WJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S52-S63. PubMed ID: 30033809
[TBL] [Abstract][Full Text] [Related]
6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis.
Cho S; Yang HC; Rhee WJ
Biosens Bioelectron; 2019 Dec; 146():111749. PubMed ID: 31600625
[TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers of prostate cancer.
Fujita K; Nonomura N
Int J Urol; 2018 Sep; 25(9):770-779. PubMed ID: 30129068
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D
Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817
[TBL] [Abstract][Full Text] [Related]
11. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A
Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
Filella X; Foj L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
[TBL] [Abstract][Full Text] [Related]
13. Exosomal noncoding RNAs in prostate cancer.
Movahedpour A; Khatami SH; Karami N; Vakili O; Naeli P; Jamali Z; Shabaninejad Z; Tazik K; Behrouj H; Ghasemi H
Clin Chim Acta; 2022 Dec; 537():127-132. PubMed ID: 36330945
[TBL] [Abstract][Full Text] [Related]
14. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
15. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miRNAs-a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer.
Chowdhury SG; Ray R; Karmakar P
Funct Integr Genomics; 2022 Dec; 23(1):23. PubMed ID: 36574059
[TBL] [Abstract][Full Text] [Related]
17. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV
Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440
[TBL] [Abstract][Full Text] [Related]
18. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
Kim J; Shim JS; Han BH; Kim HJ; Park J; Cho IJ; Kang SG; Kang JY; Bong KW; Choi N
Biosens Bioelectron; 2021 Nov; 192():113504. PubMed ID: 34298498
[TBL] [Abstract][Full Text] [Related]
19. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
Joyce DP; Kerin MJ; Dwyer RM
Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNA: a novel biomarker for breast cancer.
He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]